Alfred Sandrock's Net Worth

$29.5 Million

Estimate Recalculated Nov 8, 2024 09:32PM EST

Who is Alfred Sandrock

Alfred Sandrock has an estimated net worth of $29.5 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., NEUROCRINE BIOSCIENCES INC, and Voyager Therapeutics, Inc..

SEC CIK

Alfred Sandrock's CIK is 0001577061

Past Insider Trading and Trends

2014 was Alfred Sandrock's most active year for acquiring shares with 7 total transactions. Alfred Sandrock's most active month to acquire stocks was the month of January. 2015 was Alfred Sandrock's most active year for disposing of shares, totalling 24 transactions. Alfred Sandrock's most active month to dispose stocks was the month of January. 2013 saw Alfred Sandrock paying a total of $1,397,779.80 for 24,850 shares, this is the most they've acquired in one year. In 2013 Alfred Sandrock cashed out on 50,533 shares for a total of $6,355,832.06, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOGEN IDEC INC.

Head Research & Development
Updated Jun 09, 2021
Form 4
-43.00%
-7.67K
$440.00
-$3.38M
Jun 09, 2021
10.17K
Sale
ScheduledJun 07
Form 4
14.50K
Feb 22, 2021
14.50K
Grant
Feb 18
Form 4
-24.10%
-9.28K
$278.03
-$975.89K
Feb 17, 2021
29.23K
Options
Feb 12
Form 4
28.53%
3.73K
Jan 29, 2021
16.79K
Grant
Jan 27
Form 4
-10.30%
-1.50K
$350.00
-$525.00K
Nov 06, 2020
13.07K
Sale
ScheduledNov 04
Form 4
-9.12%
-1.45K
$333.00
-$179.15K
Feb 19, 2020
14.48K
Options
Feb 15
Form 4
24.37%
6.96K
$331.76
-$630.68K
Feb 14, 2020
35.52K
Options
Feb 12
Form 4
-13.02%
-1.56K
$325.33
-$240.42K
Feb 26, 2019
10.41K
Options
Feb 22
Form 4
-10.72%
-1.39K
$332.87
-$195.06K
Feb 20, 2019
11.61K
Options
Feb 15
Form 4
23.88%
5.17K
$319.43
-$804.32K
Feb 14, 2019
26.82K
Options
Feb 12
Form 4
-3.80%
-259.00
$290.83
-$75.32K
Feb 28, 2018
6.55K
Sale
ScheduledFeb 27
Form 4
-20.07%
-1.71K
$293.32
-$327.34K
Feb 27, 2018
6.81K
Sale
ScheduledFeb 23
Form 4
-13.64%
-1.57K
$284.81
-$207.06K
Feb 26, 2018
9.94K
Options
Feb 22
Form 4
-10.18%
-743.00
$292.00
-$216.96K
Feb 21, 2018
6.55K
Sale
ScheduledFeb 20
Form 4
-15.06%
-1.29K
$298.85
-$386.71K
Feb 20, 2018
7.30K
Sale
ScheduledFeb 15
Form 4
-9.72%
-1.38K
$299.38
-$178.43K
Feb 20, 2018
12.84K
Options
Feb 15
Form 4
63.60%
8.89K
$316.63
-$416.69K
Feb 14, 2018
22.87K
Options
Feb 12
Form 4
-21.91%
-1.98K
$274.08
-$542.95K
Apr 04, 2017
7.06K
Sale
ScheduledApr 03
Form 4
-9.72%
-973.00
$290.07
-$282.24K
Mar 03, 2017
9.04K
Sale
ScheduledMar 01
Form 4
-24.26%
-7.33K
$278.17
-$829.22K
Mar 02, 2017
22.86K
Options
Feb 28
Form 4
6.38K
Feb 17, 2017
6.38K
Grant
Feb 15
Form 4
-2.24%
-183.00
$261.90
-$47.93K
Feb 26, 2016
7.99K
Sale
ScheduledFeb 25
Form 4
-7.68%
-853.00
$258.99
-$42.47K
Feb 25, 2016
10.25K
Options
Feb 23
Form 4
7.27K
Feb 24, 2016
7.27K
Grant
Feb 22
Form 4
-8.29%
-722.00
$256.16
-$184.95K
Feb 19, 2016
7.99K
Sale
ScheduledFeb 17
Form 4
-16.35%
-4.49K
$247.22
-$451.67K
Feb 17, 2016
22.95K
Options
Feb 12
Form 4
-14.17%
-1.28K
$247.95
-$316.88K
Feb 10, 2016
7.74K
Sale
ScheduledFeb 08 - Feb 09
Form 4
-9.73%
-834.00
$276.26
-$230.40K
Dec 07, 2015
7.74K
Sale
ScheduledDec 03 - Dec 04
Form 4
-4.78%
-430.00
$430.12
-$184.95K
Mar 30, 2015
8.57K
Sale
ScheduledMar 27
Form 4
-39.99%
-6.00K
$409.54
-$2.46M
Mar 03, 2015
9.00K
Sale
ScheduledMar 01 - Mar 02
Form 4
3.11K
Feb 25, 2015
3.11K
Grant
Feb 23
Form 4
-2.71%
-418.00
$389.11
-$162.65K
Feb 18, 2015
15.00K
Sale
ScheduledFeb 17
Form 4
-6.09%
-1.28K
$392.11
-$296.83K
Feb 17, 2015
19.68K
Options
Feb 12
Form 4
-7.27%
-1.14K
$398.11
-$455.04K
Feb 11, 2015
14.57K
Sale
ScheduledFeb 10
Form 4
-10.33%
-1.96K
$398.49
-$780.25K
Feb 10, 2015
17.00K
Sale
ScheduledFeb 08 - Feb 09
Form 4
-5.41%
-833.00
$346.57
-$288.69K
Dec 05, 2014
14.57K
Sale
ScheduledDec 03 - Dec 04
Form 4
-17.07%
-3.17K
$342.58
-$1.09M
Mar 05, 2014
15.41K
Sale
ScheduledMar 04
Form 4
-13.22%
-2.83K
$340.68
-$963.78K
Mar 04, 2014
18.58K
Tax
Mar 03
Form 4
-4.67%
-1.05K
$342.17
-$358.59K
Feb 27, 2014
21.41K
Sale
ScheduledFeb 26
Form 4
-4.02%
-940.00
$347.11
-$326.28K
Feb 25, 2014
22.46K
Options
Feb 23
Form 4
144.23%
24.29K
$319.49
-$253.03K
Feb 14, 2014
41.13K
Sell-Options
ScheduledFeb 12 - Feb 13
Form 4
-13.24%
-2.08K
$314.31
-$655.34K
Feb 12, 2014
13.67K
Sale
ScheduledFeb 11
Form 4
-4.80%
-1.02K
$315.54
-$320.59K
Feb 11, 2014
20.13K
Options
Feb 08 - Feb 09
Form 4
-5.74%
-833.00
$286.78
-$238.89K
Dec 05, 2013
13.67K
Sale
ScheduledDec 03 - Dec 04
Form 4
-50.90%
-15.03K
$155.34
-$2.85M
Oct 23, 2013
14.50K
Sale
ScheduledOct 22
Form 4
-40.38%
-9.82K
$144.88
-$1.87M
Sep 18, 2013
14.50K
Sale
ScheduledSep 16
Form 3/A
Jun 24, 2013
Form 3
Jun 10, 2013
14.50K
Showing 48 results

NEUROCRINE BIOSCIENCES INC

Investor
Updated May 23, 2019
Form 4
10.00K
May 23, 2019
10.00K
Grant
May 22
Form 4
12.50K
May 25, 2018
12.50K
Grant
May 24
Form 4
15.00K
Jun 08, 2017
15.00K
Grant
May 22
Form 4
15.00K
May 24, 2016
15.00K
Grant
May 20
Form 4
40.00K
Sep 04, 2015
40.00K
Grant
Sep 02
Form 3
Sep 04, 2015
Showing 6 results

Voyager Therapeutics, Inc.

President and CEO
Updated Apr 03, 2024
Form 4
-3.62%
-12.12K
$9.86
-$119.45K
Apr 03, 2024
322.84K
Sale
Apr 02
Form 4
-3.75%
-13.03K
$7.46
-$97.23K
Feb 22, 2024
334.95K
Sale
Feb 21
Form 4
178.91%
390.00K
Feb 16, 2024
607.99K
Grant
Feb 09
Form 4
-3.35%
-7.44K
$7.83
-$58.23K
Apr 05, 2023
214.62K
Sale
Apr 03
Form 4
352.75%
360.00K
Feb 22, 2023
462.06K
Grant
Feb 17
Form 4
1.04M
Mar 23, 2022
1.04M
Grant
Mar 22
Form 4
44.00K
Feb 09, 2022
44.00K
Grant
Feb 07
Form 3
Feb 09, 2022
Showing 8 results